Pegasus Partners Ltd.

13F Filings History

Latest 13F report
Q3 2024 - Nov 1, 2024
Value $
$1.07B
Signature - Title
Jon Bensemann - Compliance & Operations Associate
Location
Mequon, WI
Summary
This page shows a list of all the recent 13F filings made by Pegasus Partners Ltd.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Pegasus Partners Ltd. reported 171 stock holdings with total value $1.07B as of Q3 2024. Top holdings included ITOT, IVV, IWY, IWV, and IWX.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 171 $1.07B +$38.9M -$21.4M +$17.5M ITOT, IVV, IWY, IWV, IWX 13F-HR 11/1/2024, 12:37 PM
Q2 2024 166 $992M +$61.6M -$32.3M +$29.2M ITOT, IVV, IWY, IWV, IWR 13F-HR 8/7/2024, 05:43 PM
Q1 2024 150 $944M +$45.5M -$19M +$26.5M ITOT, IVV, IWV, IWY, IWR 13F-HR 4/24/2024, 03:50 PM
Q4 2023 143 $856M +$101M -$36.5M +$64.9M ITOT, IVV, IWV, IWR, IWY 13F-HR 2/12/2024, 02:55 PM
Q3 2023 133 $711M +$87.6M -$21.2M +$66.4M ITOT, IVV, IWV, IWR, VONV 13F-HR 11/13/2023, 03:30 PM
Q2 2023 124 $680M +$20.4M -$18.7M +$1.65M ITOT, IVV, IWR, IWV, VONV 13F-HR 8/4/2023, 12:52 PM
Q1 2023 120 $632M +$19.6M -$33.2M -$13.6M ITOT, IVV, IWR, IWV, VONV 13F-HR 5/10/2023, 10:24 AM
Q4 2022 120 $608M +$98.1M -$15.5M +$82.6M ITOT, IVV, IWV, IWR, VONV 13F-HR 2/9/2023, 11:35 AM
Q3 2022 121 $488M +$58.7M -$19.6M +$39.1M IVV, ITOT, IWV, IWR, VONV 13F-HR 11/10/2022, 12:44 PM
Q2 2022 125 $480M +$47.5M -$48.4M -$885K IVV, ITOT, IWV, VONV, IWR 13F-HR 8/12/2022, 04:04 PM
Q1 2022 136 $572M +$48.7M -$18.2M +$30.5M IVV, ITOT, VONV, IWV, IWR 13F-HR 5/13/2022, 03:10 PM
Q4 2021 142 $571M +$41.3M -$72.7M -$31.4M IVV, ITOT, VONV, IWV, IWR 13F-HR 2/9/2022, 01:22 PM
Q3 2021 161 $551M +$58M -$18M +$40M IVV, VONV, IWV, ITOT, IJH 13F-HR 11/12/2021, 02:15 PM
Q2 2021 162 $513M +$77.2M -$34.6M +$42.6M IVV, IWV, VONV, IWR, IJH 13F-HR 8/13/2021, 09:47 AM
Q1 2021 162 $456M +$93M -$52.7M +$40.4M IVV, IWV, VONV, IJH, SPY 13F-HR 5/14/2021, 09:44 AM
Q4 2020 147 $394M +$28.5M -$7.83M +$20.6M IVV, SPY, IJH, IWV, AAPL 13F-HR 2/12/2021, 02:22 PM
Q3 2020 135 $330M +$21.2M -$12.4M +$8.8M IVV, SPY, AAPL, IJH, IWV 13F-HR 11/13/2020, 03:49 PM
Q2 2020 137 $308M +$27.4M -$26.6M +$777K IVV, SPY, IJH, AAPL, IWV 13F-HR 8/12/2020, 04:42 PM
Q1 2020 125 $255M +$53.6M -$52.7M +$983K IVV, SPY, IJH, IWR, IWV 13F-HR 5/11/2020, 01:55 PM
Q4 2019 167 $328M +$41.5M -$29.8M +$11.7M IVV, IJR, IWR, AAPL, IJH 13F-HR 2/11/2020, 07:32 PM
Q3 2019 179 $293M +$55.6M -$98M -$42.4M IVV, IJR, IWR, IJH, MSFT 13F-HR 10/24/2019, 01:02 PM
Q2 2019 170 $331M +$51.2M -$69.8M -$18.6M IVV, IJR, IWR, IJH, AAPL 13F-HR 7/30/2019, 01:41 PM
Q1 2019 136 $343M +$47.8M -$84.5M -$36.8M IJR, IVV, IWR, IJH, AAPL 13F-HR 5/13/2019, 10:06 AM
Q4 2018 135 $338M +$76.2M -$106M -$29.9M IVV, IWR, IJR, MDY, IJH 13F-HR 2/1/2019, 05:24 PM
Q3 2018 137 $454M +$38.7M -$37.3M +$1.45M IJR, IVV, IJH, IWR, AAPL Restatement 11/7/2018, 11:48 AM
Q2 2018 144 $434M +$31.6M -$73.5M -$41.9M IJR, IVV, IJH, IWR, AAPL 13F-HR 7/27/2018, 12:01 PM
Q1 2018 142 $460M +$59M -$82.5M -$23.5M IJH, IVV, IJR, IWR, AAPL 13F-HR 5/9/2018, 10:43 AM
Q4 2017 156 $488M +$88.9M -$62.9M +$26.1M IJH, IVV, IJR, IWR, AAPL 13F-HR 2/7/2018, 05:46 PM
Q3 2017 153 $438M +$88M -$36.6M +$51.4M IJR, IVV, IJH, IWR, AAPL 13F-HR 11/9/2017, 12:06 PM
Q2 2017 149 $376M +$141M -$11.6M +$129M IJR, IVV, IJH, IWR, AAPL 13F-HR 8/3/2017, 06:11 PM
Q1 2017 113 $243M +$38.9M -$21.7M +$17.2M IJR, IVV, IWR, IJH, AAPL 13F-HR 4/27/2017, 12:52 PM
Q4 2016 112 $227M +$37.2M -$29.7M +$7.52M IVV, IJR, IWR, JPM, AAPL Restatement 2/27/2017, 10:41 AM
Q3 2016 112 $211M +$20.1M -$8.95M +$11.1M IVV, IWR, IJR, GSK, AAPL 13F-HR 11/7/2016, 09:58 AM
Q2 2016 113 $193M +$15.5M -$9.43M +$6.1M IVV, IWR, GSK, PFE, AAPL 13F-HR 8/9/2016, 12:43 PM
Q1 2016 110 $184M +$45.3M -$63.6M -$18.3M IVV, IWR, GSK, PFE, AAPL 13F-HR 5/12/2016, 04:43 PM
Q4 2015 93 $199M +$61.9M -$37.7M +$24.3M IVV, GE, GSK, IWR, PFE 13F-HR 1/8/2016, 12:58 PM
Q3 2015 89 $176M +$6.08M -$37.8M -$31.7M NTG, KMI, GSK, GE, PFE 13F-HR 10/5/2015, 12:34 PM
Q2 2015 99 $227M $0 $0 KMI, NTG, AAPL, BSCF, GSK 13F-HR 8/11/2015, 04:31 PM